Elevance and Mascoma step up to the IPO dinner table: feast or famine?

Yesterday, specialty chemical and fuel producer Elevance filed a $100 million initial public offering (IPO). The S-1 indicates the company had a net loss of $113.5 million in the first half of 2011, and revenues of $8.6 million in that same period. The catalytic metathesis company raised $150 millio...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Amyris partners with Ingredion to bring its Reb M sweetener to B2B market

News Commentary | May 13, 2021

With an estimated transaction value of $100 million, Ingredion will get exclusive license to sell and market Amyris' Reb M sweetener technology under this agreement. Additionally, Ingredion will also get a minority stake in Amyris' new production facility in Brazil, to be completed by Q4 2021. ... Not part of subscription

Funding momentum for cell-based meat continues as Aleph Farms raises $105 million Series B

News Commentary | July 08, 2021

L Catterton and DisruptAD, the venture capital arm of ADQ, led this Series B round, with participation from other corporate strategic investors like Thai Union Group, Cargill, and CJ CheilJedang, among others. Aleph Farms will use this funding to scale up cell‑based beef steak production and to ... Not part of subscription

NovoNutrients raises $9 million to scale its CO₂-to-protein production system

News Commentary | August 10, 2021

The funding, led by Happiness Capital, builds on a previous $4.3 million and brings NovoNutrients' total funding to $9.9 million. E2JDJ, Marinya Capital, and previous investors IndieBio and the Grantham Environmental Trust also participated in the round. NovoNutrients aims to use the funds to scale ... Not part of subscription